The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

The UK MHRA has granted marketing authorisation to Bavarian Nordic's Vimkunya vaccine for preventing the chikungunya virus.

The U.S. Health and Human Services Department says it will require placebo testing of "all new vaccines," raising questions ...

"I have tremendous confidence in the many scientists, inspectors, and staff at the FDA to help accomplish these goals and am excited to work with them," said new FDA commissioner Dr Marty Makary ...